Medicines Co. (MDCO) Reports Q2 Loss of $1.02/Share

Medicines Co. (NASDAQ: MDCO) reported Q2 EPS of ($1.02), versus ($0.69) reported last year. Revenue for the quarter came in at $18.7 million, versus $54.73 million reported last year.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c